4.3 Review

Peroxisome proliferator-activated receptors (PPARs) are potential drug targets for cancer therapy

Journal

ONCOTARGET
Volume 8, Issue 36, Pages 60704-60709

Publisher

IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.19610

Keywords

PPARs; ligands; cancer therapy; cell signaling

Funding

  1. National Natural Science Foundation of China [81672711]
  2. Wujin Sci Tech Progran [WS201505]
  3. innovative and entrepreneurial talent of Jiangsu Province

Ask authors/readers for more resources

Peroxisome-proliferator-activated receptors (PPARs) are nuclear hormone receptors including PPAR alpha, PPAR delta and PPAR gamma, which play an important role in regulating cancer cell proliferation, survival, apoptosis, and tumor growth. Activation of PPARs by endogenous or synthetic compounds regulates tumor progression in various tissues. Although each PPAR isotype suppresses or promotes tumor development depending on the specific tissues or ligands, the mechanism is still unclear. In this review, we summarized the regulative mechanism of PPARs on cancer progression.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available